Home » Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon: Vardhan
CORONA Exclusive

Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon: Vardhan

Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon: Vardhan NEW DELHI 20 Oct 2020 – Serum Institute of India and Bharat Biotech are expected to pursue late-stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, Health Minister Dr Harsh Vardhan said on Sunday.

Vardhan said the late-stage trial generally involves thousands of participants, sometimes 30,000 to 40,000.

On Saturday, India’s Dr Reddy’s Laboratories Ltd and the Russian Direct Investment Fund (RDIF) said they have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine.

The Indian Council of Medical Research (ICMR) said it will revisit its protocol for COVID-19 treatment after the WHO found some of the commonly used drugs, including remdesivir, had little or no impact on a patient’s chances of surviving, local media reported earlier on Sunday.

About the author

Anupreet Kaur

Anupreet Kaur

She's an explorer and highly passionate about writing, painting and traveling. She is dynamic and a natural leader who believes in excellent communication, fearless journalism to pen down her words with the same approach.

Add Comment

Click here to post a comment

All Time Favorite

Categories